The Pharmacy Guild has welcomed confirmation from the NSW Government that PBS co-payments for Section 100 drugs will be scrapped for the State's residents on Thursday (1 October).Read More
Hepatitis Australia posts news stories relating to viral hepatitis that may be relevant to people living with hepatitis B or C or the people working within the hepatitis health sector. News stories come from both international and Australian sources. Your comments are welcome but any inappropriate comments, or promotional comments will be removed.
Nearly 3,000 Australians with hepatitis C have progressed to severe liver disease in the last year, as thousands continue to wait for affordable access to curative medicines recommended for a government subsidy six months ago.Read More
The World Health Organization (WHO) is calling for ambitious new global targets for diagnosis, treatment and cure of viral hepatitis, signalling a major increase in momentum towards elimination of viral hepatitis by 2030.Read More
Hepatitis NSW C me community advocate Steve Gribbin of Tamworth makes an exceptionally compelling case why further delays to listing new hepatitis C treatments on the PBS are unacceptable.
Read the full news article here http://bit.ly/1Vca5Fy
The Federal Government needs to list new hepatitis C medicines on the Pharmaceutical Benefits Scheme (PBS) without further delay, according to the peak body representing the interests of a quarter of a million Australians living with the liver-destroying virus.
Responding to the latest round of Pharmaceutical Benefits Advisory Committee recommendations, Hepatitis Australia CEO Helen Tyrrell said a total of four groundbreaking curative hepatitis C therapies have now received the green light for inclusion on the PBS but so far no listing date has been confirmed.Read More